A Study of TG103 Injection Combined With Metformin in Treatment of Type 2 Diabetes Mellitus
Clinical trial NCT06235086 · COMPLETED
Trial details
- NCT number
- NCT06235086
- Sponsor
- CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-08
- Primary completion
- 2026-02-03
- Enrollment
- 632
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.